Freshfields advises Sisram Medical on the first-ever Israeli company listing on the HKSE
Freshfields Bruckhaus Deringer (“Freshfields”) has advised Sisram Medical Ltd (“Sisram Medical”) on its Hong Kong IPO.  Sisram Medical is the first Israeli incorporated company to be listed on the Hong Kong Stock Exchange (“HKSE”).

Sisram Medical is a leading global provider of energy-based medical aesthetic treatment systems.  Following the listing, Sisram Medical will remain a subsidiary of Fosun International’s pharmaceutical unit, Shanghai Fosun Pharmaceutical Group.

The deal closed on 19 September 2017 and raised total proceeds of US$125 million. The proceeds will be primarily used by Sisram Medical for expanding its sales channels and distribution networks and for strategic acquisitions.

The Freshfields team was led by corporate partners Grace Huang and David Ludwick and supported by counsel Constance Chou.